ArticleAmerican journal of hematology2015

Combination therapy with a Tmprss6 RNAi-therapeutic and the oral iron chelator deferiprone additively diminishes secondary iron overload in a mouse model of β-thalassemia intermedia.

Paul J Schmidt et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.